IL25 and breast carcinoma: Therefore, administration of anti‐IL‐25 neutralizing antibodies decreased the IL‐4‐producing CD4+ T cells and M2 macrophages and reduced metastasis of breast cancer cells into lung tissue in the MMTV‐PyMT transgenic mice model.